CareCloud Sees 94% Shareholder Support

TL;DR

CareCloud's got 94% shareholder backing on a key proposal, looks good.

AI Summary

CareCloud, Inc. filed a Definitive Additional Materials proxy statement on January 6, 2025, indicating strong shareholder support of 94% for a proposal. The filing relates to the company's annual meeting and proxy solicitation.

Why It Matters

High shareholder support for a proposal in a proxy statement suggests strong alignment between management and investors on a particular issue, potentially impacting future company strategy or governance.

Risk Assessment

Risk Level: low — The filing is a routine proxy statement indicating shareholder support, not a material event with inherent risk.

Key Numbers

• 94% — Shareholder Support (Indicates strong approval for a proposal.)

Key Players & Entities

• CareCloud, Inc. (company) — Registrant
• MTBC, Inc. (company) — Former company name
• MEDICAL TRANSCRIPTION BILLING, CORP (company) — Former company name

FAQ

Filing Documents

• formdefa14a.htm (DEFA14A) — 28KB
• defa14a_001.jpg (GRAPHIC) — 17KB
• 0001493152-25-000380.txt ( ) — 53KB

From the Filing

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under § 240.14a-12 CareCloud, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. CareCloud Announces 94% Shareholder Support for Proposal to Increase Authorized Shares SOMERSET, N.J., January 6, 2025 (GLOBE NEWSWIRE) – CareCloud, Inc . (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that approximately 94% of the shares represented by proxies submitted to-date for the common stock special meeting scheduled for January 27, 2025 (the “Special Meeting”) have voted “FOR” the Board-supported proposal to increase the number of authorized shares (the “Proposal”). The Proposal seeks to increase the Company’s authorized common stock to provide greater strategic flexibility. The additional shares will enable CareCloud to pursue future acquisitions, support organic expansion, and facilitate the potential conversion of the Company’s outstanding Series A Preferred Stock into common stock. The increase also supports other corporate objectives to position the Company for long-term growth. “We are thrilled with the overwhelming support from our shareholders for this important Proposal,” said Stephen Snyder, Co-CEO of CareCloud. “This momentum comes on the heels of a standout 2024, where CareCloud (Nasdaq: CCLD) emerged as one of the top-performing stocks with in-year appreciation of over 140%. Approval of the Proposal is vital to enhancing shareholder value and will provide us with the tools to drive sustained revenue and profitability growth in the years ahead.” The Company strongly encourages shareholders who have not yet submitted their proxies to do so before the deadline of January 23, 2025. The details of this press release summarize information from the Definitive Proxy Statement and related filings with the U.S. Securities and Exchange Commission (“SEC”). Shareholders are encouraged to review these documents in their entirety, which are available on the SEC’s website and at https://ir.carecloud.com/common-stock-special-proxy/ . Proxy solicitation efforts are ongoing, and future results may differ from current trends. About CareCloud CareCloud brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health at www.carecloud.com . Follow CareCloud on LinkedIn , X and Facebook . Important Additional Information and Where to Find It. CareCloud filed with the SEC a Definitive Proxy Statement on Schedule 14A on December 5, 2024, with respect to its future solicitation of proxies for the Special Meeting of Common Stock Shareholders (including any and all adjournments, postponements, continuations, and reschedulings thereof). The information contained in this press release is merely a summary of certain relevant portions of the Definitive Proxy Statement and it is important that shareholders review the entirety of the filing. SHAREHOLDERS ARE URGED TO READ THE DEFINITIVE PROXY CONTAIN IMPORTANT INFORMATION ABOUT CARECLOUD’S FILING . Investors and security holders may obtain copies of these documents and other documents filed with the SEC by CareCloud free of charge through the website maintained by the SEC at www.sec.gov . The Notice of the Special Meeting of Common Stock Shareholders and our Definitive Proxy Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024 are available at www.sec.gov . Forward-Looking This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, fut

View Full Filing

View this DEFA14A filing on SEC EDGAR